More SEC Filings
View Older Stories View Newer Stories-
Form 3 TMD Energy Ltd For: Mar 18 Filed by: Ng Fong Shiang
-
Form DEFA14A OUTFRONT Media Inc.
-
Form DEF 14A OUTFRONT Media Inc. For: Apr 21
-
Form D Be-Aviv Debt Fund II,
-
Form 3 Baird Medical Investment For: Apr 21 Filed by: Xu Lijian
-
Form 3 Baird Medical Investment For: Apr 21 Filed by: Qiu Quan
-
Form 424B2 HSBC USA INC /MD/
-
Form 6-K Youxin Technology Ltd For: Apr 21
-
Form 6-K ING GROEP NV For: Apr 21
-
Form 3 Baird Medical Investment For: Apr 21 Filed by: Lu Rongjian
-
Form EFFECT QWEST CORP
-
Form C/A GROMA NAV REIT, INC.
-
Form 6-K Addex Therapeutics Ltd. For: Apr 21
-
Form EFFECT Alto Neuroscience, Inc.
-
Form 6-K HDFC BANK LTD For: Apr 20
-
Form 6-K GSK plc For: Apr 21
-
Form 4 Axe Compute Inc. For: Apr 16 Filed by: Yaukey-Witter Jeremy Reese
-
Form 8-K UNITEDHEALTH GROUP INC For: Apr 21
-
Form NT 20-F CASI Pharmaceuticals, For: Dec 31
-
Form 6-K UNITED MICROELECTRONICS For: Apr 21
-
Form 8-K FIRST UNITED CORP/MD/ For: Apr 20
-
Form 3 Youlife Group Inc. For: Apr 13 Filed by: Yang Tianshi
-
Form EFFECT J.P. Morgan Real Estate
-
Form 6-K ALTERITY THERAPEUTICS For: Apr 30
-
Form EFFECT Propanc Biopharma, Inc.
-
Form 8-K Synchrony Financial For: Apr 21
-
Form EFFECT FS Credit Real Estate
-
Form PRE 14A Medicus Pharma Ltd. For: Jun 03
-
Form EFFECT RMX INDUSTRIES, INC.
-
Form EFFECT CID Holdco, Inc.
-
Form EFFECT NORTHWEST BIOTHERAPEUTIC
-
Form 8-K Synchrony Financial For: Apr 21
-
Form EFFECT YAN CHUANG GROUP INC.
-
Form C IQ121, Inc.
-
Form EFFECT Avalon GloboCare Corp.
-
Form EFFECT Aptera Motors Corp
-
Form 8-K Sagimet Biosciences Inc. For: Apr 20
-
Form 3 Axe Compute Inc. For: Apr 16 Filed by: Yaukey-Witter Jeremy Reese
-
Form 13F-HR GHP Investment Advisors, For: Mar 31
-
Form 425 Archimedes Tech SPAC Filed by: Archimedes Tech SPAC Partners II Co.
-
Form 6-K WOORI FINANCIAL GROUP For: Apr 21
-
Form EFFECT Alamar Biosciences, Inc.
-
Form N-2/A Tap US Private Equity
-
Form S-1 East West Ave Acquisitio
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form EFFECT AN2 Therapeutics, Inc.
-
Form 424B3 GOLDMAN SACHS GROUP INC
-
Form 424B3 GOLDMAN SACHS GROUP INC
-
Form D/A Fund FG-HIS, a series

